REQUEST A DEMO
Total
USD $0.00
Search more companies

Vaxcell-Bio Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vaxcell-Bio Co.,Ltd. Profile Updated: July 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Vaxcell-Bio Co.,Ltd. is an enterprise based in South Korea. Its main office is in Hwaseong. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on February 18, 2010. Vaxcell-Bio Co.,Ltd. currently employs 91 (2025) people. From the latest financial highlights, Vaxcell-Bio Co.,Ltd. reported a net sales revenue increase of 5664.54% in Q12026. Its total assets decreased by 23.58% over the same period. The enterprise’s net profit margin increased by 8940.91% in 2026.

Headquarters
12-55, Sandan-Gil, Hwasun-Eup
Hwaseong; Gyeonggi;

Contact Details: Purchase the Vaxcell-Bio Co.,Ltd. report to view the information.

Website: http://www.vaxcell-bio.com

Basic Information
Total Employees:
Purchase the Vaxcell-Bio Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Vaxcell-Bio Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Vaxcell-Bio Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Vaxcell-Bio Co.,Ltd. report to view the information.
Incorporation Date:
February 18, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜박셀바이오
Company Performance
Financial values in the chart are available after Vaxcell-Bio Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5664.54%
Total Operating Revenue
4236.91%
Operating Profit
-32.72%
EBITDA
-20.6%
Net Profit/Loss for the Period
-61.97%
Total Assets
-23.58%
Total Equity
-29.48%
Operating Profit Margin
11915.38%
Net Profit Margin
8940.91%
Return on Equity (ROE)
-3.92%
Debt / Equity
2.47%
Quick Ratio
-23.49%
Cash Ratio
1.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?